[{"data":1,"prerenderedAt":164},["ShallowReactive",2],{"drug-bilastine":3},{"id":4,"schemaVersion":5,"name":6,"category":9,"class":10,"brands":13,"synonyms":17,"formulations":21,"regimens":36,"contraindications":70,"warnings":80,"renal":88,"monitoring":89,"interactions":90,"review":91,"examples":94,"atc":103,"iran":105,"links":121,"populations":131},"bilastine",1,{"fa":7,"en":8},"بیلاستین","Bilastine","respiratory",{"fa":11,"en":12},"آنتی‌هیستامین نسل دوم","Second-generation antihistamine",[14],{"name":15,"market":16},"Ilaxten","GB",[18,19,7,20],"ilaxten","bilaxten","بیلاکستن",[22],{"id":23,"form":24,"route":25,"label":26,"concentration":27,"markets":31,"refs":32},"tab-20","tablet","oral","20 mg tablet",{"amount":28,"unit":29,"perUnit":24,"scored":30},20,"mg",false,[16],[33],{"source":34,"section":35},"uk-smpc-ilaxten","2",[37,59],{"id":38,"disease":39,"label":40,"population":43,"type":47,"unit":29,"dose":48,"refs":49,"notes":52},"ar","allergic-rhinitis",{"fa":41,"en":42},"رینوکونژنکتیویت آلرژیک — ۱۲ سال به بالا: ۲۰ mg یک بار در روز","Allergic rhinoconjunctivitis — ≥12 y: 20 mg once daily",{"minAge":44},{"value":45,"unit":46},12,"year","fixed",{"perDose":28,"dosesPerDay":5},[50],{"source":34,"section":51},"4.2",[53],{"text":54,"refs":57},{"fa":55,"en":56},"یک ساعت قبل یا دو ساعت بعد از غذا یا آب‌میوه.","One hour before or two hours after food or fruit juice.",[58],{"source":34,"section":51},{"id":60,"disease":61,"label":62,"population":65,"type":47,"unit":29,"dose":67,"refs":68},"urticaria","chronic-urticaria",{"fa":63,"en":64},"کهیر — ۱۲ سال به بالا: ۲۰ mg یک بار در روز","Urticaria — ≥12 y: 20 mg once daily",{"minAge":66},{"value":45,"unit":46},{"perDose":28,"dosesPerDay":5},[69],{"source":34,"section":51},[71],{"id":72,"severity":73,"text":74,"refs":77},"hyper","block",{"fa":75,"en":76},"حساسیت به بیلاستین.","Hypersensitivity to bilastine.",[78],{"source":34,"section":79},"4.3",[81],{"text":82,"refs":85},{"fa":83,"en":84},"در نارسایی متوسط یا شدید کلیه، مصرف با مهارکننده‌های P-gp (کتوکونازول، اریترومایسین، سیکلوسپورین، ریتوناویر، دیلتیازم) پرهیز شود.","In moderate\u002Fsevere renal impairment avoid P-gp inhibitors (ketoconazole, erythromycin, ciclosporin, ritonavir, diltiazem).",[86],{"source":34,"section":87},"4.4",[],[],[],{"status":92,"reviewer":93,"date":93},"unverified",null,[95,100],{"regimen":38,"formulation":23,"input":96,"expect":99},{"ageYears":97,"weightKg":98},30,70,{"perDose":28,"tabletsPerDoseRounded":5},{"regimen":60,"formulation":23,"input":101,"expect":102},{"ageYears":97,"weightKg":98},{"perDose":28},[104],"R06AX29",{"status":106,"forms":107,"refs":116},"registered",[108,112],{"code":109,"en":110,"fa":111},"53442","BILASTINE 20 MG TABLET","قرص بیلاستین ۲۰ میلی‌گرم",{"code":113,"en":114,"fa":115},"53444","BILASTINE SOLUTION ORAL 2.5 mg\u002F1mL 120 ml","محلول خوراکی بیلاستین ۲٫۵ میلی‌گرم \u002F ۱ میلی‌لیتر ۱۲۰ میلی‌لیتر",[117],{"source":118,"section":119,"url":120},"darooyab-generic","G-5543\u002FBilastine","https:\u002F\u002Fwww.darooyab.ir\u002FG-5543\u002FBilastine",[122,125,127],{"kind":123,"url":124,"label":104},"who-atc","https:\u002F\u002Fatcddd.fhi.no\u002Fatc_ddd_index\u002F?code=R06AX29",{"kind":126,"url":120,"label":8},"darooyab",{"kind":128,"url":129,"label":130},"emc","https:\u002F\u002Fwww.medicines.org.uk\u002Femc\u002Fproduct\u002F4551\u002Fsmpc","UK SmPC Ilaxten 20mg",{"pregnancy":132,"lactation":141,"pediatric":148,"geriatric":156},{"level":133,"text":134,"quote":137,"refs":138},"caution",{"fa":135,"en":136},"برچسب خطر مشخصی برای بارداری ذکر نکرده یا داده کافی ندارد؛ فقط در صورت لزوم و با نظر پزشک.","Label states no clear risk or has limited data; use only if needed, under medical advice.",": There are no or limited amount of data from the use of bilastine in pregnant women.",[139],{"source":34,"section":140},"4.6",{"level":133,"text":142,"quote":145,"refs":146},{"fa":143,"en":144},"برچسب: در شیردهی با احتیاط؛ متن برچسب را ببینید.","Label: use with caution while breastfeeding; see the label text.",": The excretion of bilastine in milk has not been studied in humans.",[147],{"source":34,"section":140},{"level":149,"text":150,"quote":153,"refs":154},"not-established",{"fa":151,"en":152},"برچسب: ایمنی و اثربخشی در کودکان ثابت نشده است.","Label: safety and effectiveness in children have not been established.","The safety and efficacy of bilastine in renally and hepatically impaired children have not been established.",[155],{"source":34,"section":51},{"level":157,"text":158,"quote":161,"refs":162},"ok",{"fa":159,"en":160},"برچسب: در سالمندان تفاوت یا تنظیم دوز خاصی ذکر نشده.","Label: no specific difference or dose adjustment stated for older adults.","Elderly No dosage adjustments are required in elderly patients (see sections 5.1 and 5.2).",[163],{"source":34,"section":51},1792092024576]